[Federal Register Volume 88, Number 19 (Monday, January 30, 2023)]
[Notices]
[Pages 5883-5884]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-01802]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket No. CDC-2023-0007]


Advisory Committee on Immunization Practices

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice and request for comment.

-----------------------------------------------------------------------

SUMMARY: In accordance with regulatory provisions, the Centers for 
Disease Control and Prevention (CDC) announces the following meeting of 
the Advisory Committee on Immunization Practices (ACIP). This meeting 
is open to the public. Time will be available for public comment. The 
meeting will be webcast live via the World Wide Web.

DATES: The meeting will be held on February 22, 2023, 8 a.m. to 5:15 
p.m., EST, February 23, 2023, 8 a.m. to 5 p.m., EST, and February 24, 
2023, 8 a.m. to 1 p.m., EST (times subject to change, see the ACIP 
website for updates: http://www.cdc.gov/vaccines/acip/index.html). 
Written comments must be received between February 6-17, 2023.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2023-
0007, by any of the following methods below. CDC does not accept 
comments by email.
     Federal eRulemaking Portal: https://www.regulations.gov. 
Follow the instructions for submitting comments.
     Mail: ACIP Meeting, Centers for Disease Control and 
Prevention, 1600 Clifton Road NE, MS H24-8, Atlanta, GA 30329-4027. 
Docket No. CDC-2023-0007.
    Instructions: All submissions received must include the Agency name 
and Docket Number. All relevant comments received in conformance with 
the https://www.regulations.gov suitability policy will be posted 
without change to https://www.regulations.gov, including any personal 
information provided. For access to the docket to read background 
documents or comments received, go to https://www.regulations.gov.

[[Page 5884]]


FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee 
Management Specialist, Centers for Disease Control and Prevention, 
National Center for Immunization and Respiratory Diseases, 1600 Clifton 
Road NE, MSH24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8836; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Purpose: The committee is charged with advising the Director, CDC, 
on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, 
the committee is mandated to establish and periodically review and, as 
appropriate, revise the list of vaccines for administration to vaccine-
eligible children through the Vaccines For Children program, along with 
schedules regarding dosing interval, dosage, and contraindications to 
administration of vaccines. Further, under provisions of the Affordable 
Care Act, section 2713 of the Public Health Service Act, immunization 
recommendations of the ACIP that have been approved by the Director, 
CDC, and appear on CDC immunization schedules must be covered by 
applicable health plans.
    Matters To Be Considered: The agenda will include discussions on 
mpox vaccines, influenza vaccines, pneumococcal vaccine, rotavirus 
vaccines, varicella vaccines, meningococcal vaccines, Polio vaccine, 
respiratory syncytial virus vaccine pediatric/maternal, respiratory 
syncytial virus vaccine adult, dengue vaccines, Chikungunya vaccine, 
and COVID-19 vaccines. Recommendation votes on mpox vaccine are 
scheduled. A Vaccines For Children vote on rotavirus vaccines is 
scheduled. Agenda items are subject to change as priorities dictate. 
For more information on the meeting agenda visit https://www.cdc.gov/vaccines/acip/meetings/meetings-info.html.
    Meeting Information: The meeting will be webcast live via the World 
Wide Web; for more information on ACIP, please visit the ACIP website: 
http://www.cdc.gov/vaccines/acip/index.html.

Public Participation

    Interested persons or organizations are invited to participate by 
submitting written views, recommendations, and data. Please note that 
comments received, including attachments and other supporting 
materials, are part of the public record and are subject to public 
disclosure. Comments will be posted on https://www.regulations.gov. 
Therefore, do not include any information in your comment or supporting 
materials that you consider confidential or inappropriate for public 
disclosure. If you include your name, contact information, or other 
information that identifies you in the body of your comments, that 
information will be on public display. CDC will review all submissions 
and may choose to redact, or withhold, submissions containing private 
or proprietary information such as Social Security numbers, medical 
information, inappropriate language, or duplicate/near duplicate 
examples of a mass-mail campaign. CDC will carefully consider all 
comments submitted into the docket. CDC does not accept comments by 
email.
    Written Public Comment: The docket will be opened to receive 
written comments on February 6, 2023. Written comments must be received 
by February 17, 2023.
    Oral Public Comment: This meeting will include time for members of 
the public to make an oral comment. Oral public comment will occur 
before any scheduled votes including all votes relevant to the ACIP's 
Affordable Care Act and Vaccines For Children Program roles. Priority 
will be given to individuals who submit a request to make an oral 
public comment before the meeting according to the procedures below.
    Procedure for Oral Public Comment: All persons interested in making 
an oral public comment at the February 22, 2023 ACIP meeting must 
submit a request at http://www.cdc.gov/vaccines/acip/meetings/ no later 
than 11:59 p.m., EST, February 17, 2023 according to the instructions 
provided.
    If the number of persons requesting to speak is greater than can be 
reasonably accommodated during the scheduled time, CDC will conduct a 
lottery to determine the speakers for the scheduled public comment 
session. CDC staff will notify individuals regarding their request to 
speak by email by February 20, 2023. To accommodate the significant 
interest in participation in the oral public comment session of ACIP 
meetings, each speaker will be limited to three minutes, and each 
speaker may only speak once per meeting.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-01802 Filed 1-27-23; 8:45 am]
BILLING CODE 4163-18-P